1-5 of 5
Authors: Claudia Nader
Journal Article
2789. Cefepime Versus Non-Cefepime/Non-Carbapenem Therapy for Blood Stream Infections Caused by Non-ESBL-Producing Serratia Marcescens: A Subgroup Analysis of The Carbapenem-Serratia Multicenter Retrospective Cohort Study Open Access
Open Forum Infectious Diseases, Volume 10, Issue Supplement_2, December 2023, ofad500.2400, https://doi.org/10.1093/ofid/ofad500.2400
Published: 27 November 2023
Journal Article
2788. Cefepime or Carbapenem Definitive Therapy Versus Other Antibiotics for Blood Stream Infections Caused by Non-ESBL-Producing Serratia Marcescens: A Multicenter Retrospective Cohort Study Open Access
Open Forum Infectious Diseases, Volume 10, Issue Supplement_2, December 2023, ofad500.2399, https://doi.org/10.1093/ofid/ofad500.2399
Published: 27 November 2023
Journal Article
2787. Carbapenem Versus Non-Carbapenem Based Therapy for Blood Stream Infection Caused by Serratia Marcescens: A Multicenter Retrospective Cohort Study Open Access
Open Forum Infectious Diseases, Volume 10, Issue Supplement_2, December 2023, ofad500.2398, https://doi.org/10.1093/ofid/ofad500.2398
Published: 27 November 2023
Journal Article
698. 8 Years of Infective Endocarditis in Intravenous and Non-Intravenous Drug Users a Single Center Experience Open Access
Open Forum Infectious Diseases, Volume 7, Issue Supplement_1, October 2020, Pages S400–S401, https://doi.org/10.1093/ofid/ofaa439.890
Published: 31 December 2020
Journal Article
697. 8 Years of Characteristics and Outcomes of Patients with MRSA Endocarditis Based on Vancomycin Minimum Inhibitory Concentration: Experience at a Tertiary Care Hospital Open Access
Open Forum Infectious Diseases, Volume 7, Issue Supplement_1, October 2020, Page S400, https://doi.org/10.1093/ofid/ofaa439.889
Published: 31 December 2020
